TP53 and neoplasm: A large tumour size, nodal involvement and poor clinical outcomes for women with TNBC may in part be explained by intrinsically aggressive tumour pathology, including high mitotic index, high histologic grade, high proliferation, and a high frequency of TP53 mutations associated with a frequent occurrence of visceral metastases and poor prognosis [1,2].